BridgeMD
New treatment option for Phantom Limb Pain After Amputation
Official title Clinical Application Observation on the Evaluation of Phantom Limb Pain With the Suralis System
ClinicalTrials.gov ID: NCT07324109
What this study is testing
- What it's testing
- This study tests whether a vibration-based feedback device (Suralis) can reduce phantom limb pain in people with lower-leg amputations over 3 weeks. Participants wear the device daily and report pain levels, walking ability, and quality of life - with no known risks, as it's a CE-certified medical device.
- Time commitment: about 3 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Unilateral major lower-limb amputation (transtibial or transfemoral)
- Presence of persistent phantom limb pain, defined as daily pain intensity ≥ 3/10 on the Visual Analog Scale (VAS) during the baseline period
- Regular daily use of a prosthetic limb (minimum 4 hours/day)
- Adequate German language proficiency to understand and complete study questionnaires and follow study procedures
- Ability to provide informed consent
You likely can't join if
- Unstable wound or skin condition at the residual limb
- Inconsistent prosthetic use (less than daily or \< 4 hours/day)
- Poorly fitting or non-functional prosthesis (as determined by study team)
- Incapacity to provide informed consent (e.g., due to cognitive impairment or severe psychiatric illness)
- Insufficient German language skills to comprehend study materials or complete assessments reliably
The study team makes the final eligibility decision.
Where it's taking place
- Wiesbaden, Hesse, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wiesbaden, Hesse, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.